CureVac NV (CVAC)
3.89
+0.12
(+3.18%)
USD |
NASDAQ |
May 31, 16:00
3.88
-0.01
(-0.26%)
After-Hours: 20:00
CureVac Free Cash Flow: -339.08M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -339.08M |
| December 31, 2023 | -349.78M |
| September 30, 2023 | -376.79M |
| June 30, 2023 | -346.55M |
| March 31, 2023 | -348.74M |
| December 31, 2022 | -400.11M |
| Date | Value |
|---|---|
| September 30, 2022 | -572.13M |
| June 30, 2022 | -860.52M |
| March 31, 2022 | -910.60M |
| December 31, 2021 | -1.019B |
| September 30, 2021 | -767.33M |
| June 30, 2021 | -457.17M |
Free Cash Flow Range, Past 5 Years
-1.019B
Minimum
Dec 2021
-339.08M
Maximum
Mar 2024
-562.30M
Average
-428.64M
Median
Free Cash Flow Benchmarks
| BioNTech SE | 5.344B |
| Affimed NV | -123.42M |
| InflaRx NV | -45.89M |
| MorphoSys AG | -- |
| Immatics NV | -29.05M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -104.88M |
| Cash from Investing (Quarterly) | -5.527M |
| Cash from Financing (Quarterly) | -1.221M |
| Free Cash Flow Per Share (Quarterly) | -0.4922 |
| Free Cash Flow to Equity (Quarterly) | -110.40M |
| Free Cash Flow to Firm (Quarterly) | -110.40M |
| Free Cash Flow Yield | -38.91% |